<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font21">CH-), </span>
   <span class="font19">and </span>
   <span class="font17">(), </span>
   <span class="font15">(pyrrolizine </span>
   <span class="font15">compound </span>
   <span class="font15">was </span>
   <span class="font14">The </span>
   <span class="font14">Jâ€‰=â€‰.â€‰Hz, </span>
   <span class="font14">with </span>
   <span class="font14">(naphthalenyl </span>
   <span class="font13">compounds </span>
   <span class="font13">CH-â€‰â€‰CH-), </span>
   <span class="font13">C-), </span>
   <span class="font12">CDK- </span>
   <span class="font12">were </span>
   <span class="font12">against </span>
   <span class="font12">.â€‰Â±â€‰. </span>
   <span class="font12">(d, </span>
   <span class="font12">(Ph </span>
   <span class="font12">for </span>
   <span class="font12">new </span>
   <span class="font11">(t, </span>
   <span class="font11">pyrrolizine </span>
   <span class="font11">(s, </span>
   <span class="font11">â€‰MHz, </span>
   <span class="font11">ppm): </span>
   <span class="font11">cell </span>
   <span class="font11">activity </span>
   <span class="font11">three </span>
   <span class="font11">Figure </span>
   <span class="font11">into </span>
   <span class="font11">inhibitory </span>
   <span class="font11">results </span>
   <span class="font11">study </span>
   <span class="font11">naphthalenyl </span>
   <span class="font11">(m, </span>
   <span class="font11">.â€". </span>
   <span class="font11">(hexyl </span>
   <span class="font11">MCF- </span>
   <span class="font11">Table </span>
   <span class="font11">cells </span>
   <span class="font11">docking </span>
   <span class="font11">also </span>
   <span class="font11">cytotoxic </span>
   <span class="font11">hydrogen </span>
   <span class="font11">(.â€‰g, </span>
   <span class="font11">(CN), </span>
   <span class="font11">Compound </span>
   <span class="font11">derivatives </span>
   <span class="font11">from </span>
   <span class="font11">(DMSO, </span>
   <span class="font11">binding </span>
   <span class="font11">revealed </span>
   <span class="font11">{background </span>
   <span class="font11">according </span>
   <span class="font11">which </span>
   <span class="font11">C-a), </span>
   <span class="font11">active </span>
   <span class="font11">activities </span>
   <span class="font10">cancer </span>
   <span class="font10">compared </span>
   <span class="font10">hexyl </span>
   <span class="font10">higher </span>
   <span class="font10">kinase </span>
   <span class="font10">their </span>
   <span class="font10">F-Ph </span>
   <span class="font10">exhibited </span>
   <span class="font10">inhibitors </span>
   <span class="font10">using </span>
   <span class="font10">CH), </span>
   <span class="font10">Câ€"H), </span>
   <span class="font10">potent </span>
   <span class="font10">margin </span>
   <span class="font10">solid </span>
   <span class="font10">these </span>
   <span class="font10">(tolyl </span>
   <span class="font10">Med </span>
   <span class="font10">obtained </span>
   <span class="font10">previous </span>
   <span class="font10">towards </span>
   <span class="font10">urea </span>
   <span class="font10">{border-style </span>
   <span class="font10">â€" </span>
   <span class="font10">([Mâ€‰â€‰], </span>
   <span class="font10">Yes </span>
   <span class="font10">assay </span>
   <span class="font10">cytotoxicity </span>
   <span class="font10">interactions </span>
   <span class="font10">prepared </span>
   <span class="font10">reaction </span>
   <span class="font10">(MeO-Ph </span>
   <span class="font10">Among </span>
   <span class="font10">px;} </span>
   <span class="font10">range </span>
   <span class="font10">virtual </span>
   <span class="font10">white </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">(%) </span>
   <span class="font10">.... </span>
   <span class="font10">DEPT </span>
   <span class="font10">addition, </span>
   <span class="font10">amorphous </span>
   <span class="font10">general </span>
   <span class="font10">that </span>
   <span class="font10">used </span>
   <span class="font10">Chem;:â€". </span>
   <span class="font10">anticancer </span>
   <span class="font10">could </span>
   <span class="font10">procedure </span>
   <span class="font10">ring </span>
   <span class="font10">than </span>
   <span class="font10">âˆ’. </span>
   <span class="font10">(). </span>
   <span class="font10">(.): </span>
   <span class="font10">(Câ€‰=â€‰C, </span>
   <span class="font10">(EI): </span>
   <span class="font10">(NHs), </span>
   <span class="font10">.â€‰mmol) </span>
   <span class="font10">Anal. </span>
   <span class="font10">CDK </span>
   <span class="font10">Calcd. </span>
   <span class="font10">Câ€‰=â€‰N), </span>
   <span class="font10">Found: </span>
   <span class="font10">H-NMR </span>
   <span class="font10">IRÊ‹max/cmâˆ’ </span>
   <span class="font10">m.p. </span>
   <span class="font10">m/z </span>
   <span class="font10">product, </span>
   <span class="font10">selectivity </span>
   <span class="font10">title </span>
   <span class="font10">yield </span>
   <span class="font10">â€"â€‰Â°C, </span>
   <span class="font10">â€‰C-NMR </span>
   <span class="font10">â€‰mmol) </span>
   <span class="font10">(Cl-Ph </span>
   <span class="font10">(Câ€"N, </span>
   <span class="font10">(DMSO-d, </span>
   <span class="font10">(pdb: </span>
   <span class="font10">CDK-, </span>
   <span class="font10">CDK-. </span>
   <span class="font10">CH-CH-), </span>
   <span class="font10">Moreover, </span>
   <span class="font10">molecular </span>
   <span class="font10">most </span>
   <span class="font10">novel </span>
   <span class="font10">screening </span>
   <span class="font10">several </span>
   <span class="font10">studies </span>
   <span class="font10">(COs), </span>
   <span class="font10">(aliphatic </span>
   <span class="font10">aâ€"c </span>
   <span class="font10">bond </span>
   <span class="font10">cells. </span>
   <span class="font10">isocyanate </span>
   <span class="font10">lines </span>
   <span class="font10">performed </span>
   <span class="font10">potential </span>
   <span class="font10">showed </span>
   <span class="font10">this </span>
   <span class="font10">values </span>
   <span class="font10">(IC </span>
   <span class="font10">(NHCONH), </span>
   <span class="font10">([M-], </span>
   <span class="font10">(aromatic </span>
   <span class="font10">... </span>
   <span class="font10">based </span>
   <span class="font10">chemical </span>
   <span class="font10">data </span>
   <span class="font10">drug </span>
   <span class="font10">highest </span>
   <span class="font10">one </span>
   <span class="font10">cycle </span>
   <span class="font10">discovery </span>
   <span class="font10">displayed </span>
   <span class="font10">groups </span>
   <span class="font10">ligand </span>
   <span class="font10">moiety </span>
   <span class="font10">pharmacophoric </span>
   <span class="font10">site </span>
   <span class="font10">two </span>
   <span class="font10">(CH), </span>
   <span class="font10">.â€‰nM </span>
   <span class="font10">CDKs </span>
   <span class="font10">CH-â€‰â€‰CH-). </span>
   <span class="font10">GoudaAM, </span>
   <span class="font10">apoptosis </span>
   <span class="font10">bonds </span>
   <span class="font10">conventional </span>
   <span class="font10">evaluated </span>
   <span class="font10">evaluation </span>
   <span class="font10">number </span>
   <span class="font10">other </span>
   <span class="font10">report. </span>
   <span class="font10">reported </span>
   <span class="font10">scaffold </span>
   <span class="font10">value </span>
   <span class="font10">while </span>
   <span class="font10">([M], </span>
   <span class="font10">Drug </span>
   <span class="font10">These </span>
   <span class="font10">bearing </span>
   <span class="font10">calculated </span>
   <span class="font10">current </span>
   <span class="font10">derivatives, </span>
   <span class="font10">hydrophobic </span>
   <span class="font10">mode </span>
   <span class="font10">native </span>
   <span class="font10">protein </span>
   <span class="font10">pyrrolizine-NHCO), </span>
   <span class="font10">treatment </span>
   <span class="font10">-fluorophenyl </span>
   <span class="font10">Leu </span>
   <span class="font10">Lipinskiâ€™s </span>
   <span class="font10">Ph-NHCO). </span>
   <span class="font10">are </span>
   <span class="font10">cyclin-dependent </span>
   <span class="font10">different </span>
   <span class="font10">have </span>
   <span class="font10">high </span>
   <span class="font10">pharmacophore </span>
   <span class="font10">px; </span>
   <span class="font10">respectively. </span>
   <span class="font10">structure </span>
   <span class="font10">{font-family </span>
   <span class="font10">(Ph-NHCO). </span>
   <span class="font10">-naphthalenyl </span>
   <span class="font10">Gln </span>
   <span class="font10">However, </span>
   <span class="font10">MRC- </span>
   <span class="font10">MTT </span>
   <span class="font10">affinities </span>
   <span class="font10">agents. </span>
   <span class="font10">amino </span>
   <span class="font10">between </span>
   <span class="font10">done </span>
   <span class="font10">features </span>
   <span class="font10">font-size </span>
   <span class="font10">free </span>
   <span class="font10">hits </span>
   <span class="font10">increase </span>
   <span class="font10">inÂ </span>
   <span class="font10">its </span>
   <span class="font10">library </span>
   <span class="font10">lines. </span>
   <span class="font10">normal </span>
   <span class="font10">replacement </span>
   <span class="font10">selected </span>
   <span class="font10">shown </span>
   <span class="font10">(OCH), </span>
   <span class="font10">(a) </span>
   <span class="font10">(b) </span>
   <span class="font10">(c) </span>
   <span class="font10">-methoxyphenyl </span>
   <span class="font10">-naphthyl </span>
   <span class="font10">ADME </span>
   <span class="font10">CHNO </span>
   <span class="font10">Chem </span>
   <span class="font10">Câ€"O). </span>
   <span class="font10">Câ€"O, </span>
   <span class="font10">Eur </span>
   <span class="font10">Faculty </span>
   <span class="font10">MeO-Ph </span>
   <span class="font10">Pharmacy, </span>
   <span class="font10">ability </span>
   <span class="font10">aromatic </span>
   <span class="font10">arrest </span>
   <span class="font10">biological </span>
   <span class="font10">compounds, </span>
   <span class="font10">compounds. </span>
   <span class="font10">development </span>
   <span class="font10">double; </span>
   <span class="font10">drug-likeness </span>
   <span class="font10">electron </span>
   <span class="font10">evaluate </span>
   <span class="font10">group </span>
   <span class="font10">growth </span>
   <span class="font10">hand, </span>
   <span class="font10">impact </span>
   <span class="font10">inhibitors: </span>
   <span class="font10">more </span>
   <span class="font10">over </span>
   <span class="font10">presented </span>
   <span class="font10">pyrazole </span>
   <span class="font10">rule. </span>
   <span class="font10">study, </span>
   <span class="font10">tolyl </span>
   <span class="font10">â€‰b </span>
   <span class="font10">â€‰h. </span>
   <span class="font10">(A) </span>
   <span class="font10">(Table </span>
   <span class="font10">(b, </span>
   <span class="font10">-CH </span>
   <span class="font10">Accordingly, </span>
   <span class="font10">Al-Qura </span>
   <span class="font10">Annexin </span>
   <span class="font10">Bioorg </span>
   <span class="font10">CDK-/ </span>
   <span class="font10">CDK-; </span>
   <span class="font10">Compounds </span>
   <span class="font10">Enzyme </span>
   <span class="font10">RMSD </span>
   <span class="font10">Supplementary </span>
   <span class="font10">Sâ€"S). </span>
   <span class="font10">Umm </span>
   <span class="font10">acids </span>
   <span class="font10">activities. </span>
   <span class="font10">affinity </span>
   <span class="font10">afforded </span>
   <span class="font10">after </span>
   <span class="font10">al.Identification </span>
   <span class="font10">all </span>
   <span class="font10">attributed </span>
   <span class="font10">bonding </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">but </span>
   <span class="font10">cyclin </span>
   <span class="font10">design </span>
   <span class="font10">designed </span>
   <span class="font10">each </span>
   <span class="font10">following </span>
   <span class="font10">formed </span>
   <span class="font10">inhibitor </span>
   <span class="font10">investigation </span>
   <span class="font10">lines, </span>
   <span class="font10">model </span>
   <span class="font10">moderate </span>
   <span class="font10">moieties </span>
   <span class="font10">multi-CDKI </span>
   <span class="font10">phase </span>
   <span class="font10">phenyl </span>
   <span class="font10">properties </span>
   <span class="font10">silico </span>
   <span class="font10">small </span>
   <span class="font10">solid; </span>
   <span class="font10">structural </span>
   <span class="font10">substitution </span>
   <span class="font10">synthesis, </span>
   <span class="font10">target </span>
   <span class="font10">test </span>
   <span class="font10">through </span>
   <span class="font10">top-scoring </span>
   <span class="font10">urea/thiourea </span>
   <span class="font10">vitro </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Câ€"Cl). </span>
   <span class="font10">(Figures </span>
   <span class="font10">(LZ) </span>
   <span class="font10">-CH/Cl </span>
   <span class="font10">.â€".â€‰Î¼M). </span>
   <span class="font10">.â€".â€‰Î¼M. </span>
   <span class="font10">AbdallaAN, </span>
   <span class="font10">Ala, </span>
   <span class="font10">CAN </span>
   <span class="font10">CH-â€‰â€‰CH-â€‰â€‰CH-), </span>
   <span class="font10">Cl-Ph </span>
   <span class="font10">Comp. </span>
   <span class="font10">Department </span>
   <span class="font10">Docking </span>
   <span class="font10">H), </span>
   <span class="font10">Inhib </span>
   <span class="font10">Mol </span>
   <span class="font10">Naphthalen--yl-ureido </span>
   <span class="font10">Res;:â€". </span>
   <span class="font10">S). </span>
   <span class="font10">Substitution </span>
   <span class="font10">This </span>
   <span class="font10">UniversityMakkahSaudi </span>
   <span class="font10">analogues </span>
   <span class="font10">analysis </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">apoptotic </span>
   <span class="font10">appropriate </span>
   <span class="font10">atoms </span>
   <span class="font10">bold </span>
   <span class="font10">cells, </span>
   <span class="font10">clinical </span>
   <span class="font10">colon </span>
   <span class="font10">courier; </span>
   <span class="font10">decrease </span>
   <span class="font10">derivative </span>
   <span class="font10">design, </span>
   <span class="font10">determined </span>
   <span class="font10">effect </span>
   <span class="font10">em; </span>
   <span class="font10">energy </span>
   <span class="font10">fitting </span>
   <span class="font10">flavopiridol </span>
   <span class="font10">formation </span>
   <span class="font10">human </span>
   <span class="font10">included </span>
   <span class="font10">indicated </span>
   <span class="font10">induce </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibition </span>
   <span class="font10">interaction </span>
   <span class="font10">investigated </span>
   <span class="font10">isothiocyanate </span>
   <span class="font10">kinases </span>
   <span class="font10">mean </span>
   <span class="font10">mechanism </span>
   <span class="font10">palbociclib. </span>
   <span class="font10">pharmacokinetic </span>
   <span class="font10">position </span>
   <span class="font10">promising </span>
   <span class="font10">provided </span>
   <span class="font10">pt;} </span>
   <span class="font10">pyrrolizine--carboxamide </span>
   <span class="font10">pyrrolizines </span>
   <span class="font10">re-docked </span>
   <span class="font10">related </span>
   <span class="font10">relationship </span>
   <span class="font10">reports. </span>
   <span class="font10">role </span>
   <span class="font10">same </span>
   <span class="font10">screening, </span>
   <span class="font10">selective </span>
   <span class="font10">showing </span>
   <span class="font10">sites </span>
   <span class="font10">spectra </span>
   <span class="font10">studies. </span>
   <span class="font10">synthesis </span>
   <span class="font10">tested </span>
   <span class="font10">thiourea </span>
   <span class="font10">types </span>
   <span class="font10">â€"aâ€"c </span>
   <span class="font10">â€‰D </span>
   <span class="font10">â€‰h </span>
  </p>
 </body>
</html>
